Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Revenue (2016 - 2024)

Immuron (IMRN) posted Revenue of $32669.5 for Q3 2024, up 113.04% on a QoQ basis from $15334.6 in Q4 2023.

Analysis

Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends

Immuron has reported Revenue for 9 years, with the latest figure at $32669.5 in Q3 2024.

  • On a quarterly basis, Revenue changed N/A year-over-year to $32669.5 in Q3 2024; TTM through Sep 2024 was $714592.3, a N/A change from a year earlier, with the FY2026 full-year figure at $7.7 million, up 10485.42% from the prior year.
  • Revenue was $32669.5 for Q3 2024 at Immuron, up from $15334.6 in the prior quarter.
  • The five-year high for Revenue was $583646.0 in Q4 2022, with the low at $148.45 in Q4 2020.
  • Average Revenue over 5 years is $119405.2, with a median of $24002.1 recorded in 2024.
  • The sharpest annual moves came in 2020 and 2022: Revenue slumped 99.05% in 2020, then soared 34421.0% in 2022.
  • Over 5 years, Revenue stood at $148.45 in 2020, then jumped by 1038.93% to $1690.7 in 2021, then jumped by 34421.0% to $583646.0 in 2022, then sank by 97.37% to $15334.6 in 2023, then surged by 113.04% to $32669.5 in 2024.
  • The last three Revenue figures came in at $32669.5 (Q3 2024), $15334.6 (Q4 2023), and $82942.2 (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 1.44 Mn
10 Immuron 10.28 Mn 1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 32,669.51
Dec 31, 2023 15,334.60
Jun 30, 2023 82,942.19
Dec 31, 2022 583,646.00
Dec 31, 2021 1,690.70
Dec 31, 2020 148.45
Dec 31, 2019 15,566.23
Dec 31, 2018 978,233.00
Dec 31, 2017 706,852.56
Dec 31, 2016 530,121.20
Jun 30, 2016 862,831.81